双能CT联合iMAR用于EVAR术后CTA监测的前瞻性研究
本前瞻性研究纳入50例EVAR术后患者,采用Siemens Force CT行100/150 kVp双能CTA,重建常规混合图、40–190 keV虚拟单能图并比较有无iMAR。结果显示iMAR联合DECT可减少支架金属伪影、改善血管与软组织显示,90 keV(有效范围80–100 keV)可能为优选能级。
要点
- 90 keV(有效范围80–100 keV)可作为EVAR术后DECT阅片的优选能级。
- iMAR能改善支架伪影和血管可见度,伪影越重改善越明显。
- iMAR+DECT可将部分漏诊的内漏、血栓、感染转为真阳性。
核心结论
- DECT-VMI联合iMAR可有效减少EVAR术后支架相关金属伪影并改善血管与软组织显示。
- 90 keV(有效范围80–100 keV)可能为优化诊断评估的能级,但尚待更大规模多中心验证。
研究设计与样本
- 前瞻性研究,纳入50例EVAR术后患者,82%为男性,平均年龄68.7±8.9岁。
- 采用Siemens Force CT行100/150 kVp双能CTA,重建常规混合图与40–190 keV虚拟单能图,并比较有无iMAR。
- 影像质量通过定量参数和5分主观评分评估,同时记录临床资料和辐射剂量。
- 诊断性能以手术/DSA所见及盲法专家判定为参考标准。
关键影像表现/征象
- iMAR-DECT对图像质量的提升与伪影严重程度呈正相关,且iMAR对正常组织影响较小。
- 多数定量参数在40–70 keV快速下降,超过100 keV后趋于平台期。
- iMAR在伪影减少评分上于150–190 keV达平台,在血管可见度评分上于90 keV最佳。
诊断标准与关键数值
- iMAR在伪影减少和血管可见度评分方面显著优于非iMAR(P<0.01,经Bonferroni校正)。
- iMAR+DECT使5例假阴性转为真阳性(内漏、血栓、感染),敏感度有高于非iMAR+DECT的趋势(P>0.05,效应量大)。
- 支架类型间定量参数无统计学差异(P>0.05)。
临床应用与阅片要点
- EVAR术后CTA阅片可优先选择90 keV左右的DECT虚拟单能图并结合iMAR重建。
- 对支架伪影较重区域,iMAR可提高内漏、血栓及感染灶的识别能力。
- 能级选择需注意40–70 keV参数快速下降,过高能级可能进入平台期。
局限性
- 诊断效能的提升仅呈趋势,未达到统计学显著,需更大样本验证。
- 结论中提出尚需更大规模、多中心队列验证90 keV等能级的优化价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the value of dual-energy computed tomography (DECT) combined with the iterative metal artifact reduction (iMAR) for postoperative endovascular aortic repair (EVAR) CT angiography (CTA) surveillance.
METHODS: In this prospective study, post-EVAR CTA surveillance was performed using a Siemens Force CT (100/150 kVp dual-energy). Images were reconstructed as conventional mixed and 40-190 keV virtual monoenergetic images (VMIs), with and without iMAR. Image quality was assessed via quantitative parameters and 5-point subjective scores, with clinical data and radiation dose recorded simultaneously. Diagnostic performance was referenced to surgical/DSA findings and blinded expert adjudication. Statistical analysis was performed via two-way repeated-measures ANOVA with post-hoc paired t-tests or Wilcoxon tests for quantitative parameters, While subjective scores were analyzed using the Friedman test with post-hoc Wilcoxon signed-rank tests. P values were Bonferroni-corrected; corrected P < 0.05 indicated significance.
RESULTS: Fifty post-EVAR patients (82% male; 68.7 ± 8.9 years) received safe radiation doses; stent type yielded no quantitative differences (P > 0.05). iMAR-DECT synergistically enhanced image quality, with improvements correlating positively with artifact severity while sparing normal tissues for iMAR. Energy levels dominated the trend: most parameters declined rapidly at 40-70 keV but plateaued beyond 100 keV. iMAR significantly outperformed non-iMAR in scores of artifact reduction (plateauing at 150-190 keV) and vessel visibility (peaking at 90 keV, P < 0.01). For diagnosis, iMAR+DECT converted five false negatives into true positives (endoleaks, thrombosis, infection), showing a trend toward higher sensitivity than those for non-iMAR+DECT (P > 0.05, large effect size).
CONCLUSION: The integration of DECT-VMIs with the iMAR algorithm appears to improve image quality in post-EVAR CTA by effectively reducing stent-related metal artifacts while enhancing vascular and soft-tissue visualization. Based on our quantitative and qualitative assessments, an energy level of 90 keV (effective range 80-100 keV) may be considered optimal to optimize diagnostic evaluation, pending validation in larger, multi-center cohorts.
引用
- Xie, Chen, Wang, et al. Dual-energy CT with metal artifact reduction for post-EVAR CTA surveillance: a prospective study with image quality analysis. Abdom Radiol (NY). 2026. PMID: 42461421. doi:10.1007/s00261-026-05683-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。